Find Clinical Trial

Home » Find Clinical Trials » Efficacy and safety assessment of two schemes of oral administration of once-daily extended release metformin (metformin XR) in type 2 diabetic patients previously treated with metformin in combination with sulfonylurea. A 3-month, international, multicentre, randomised, double-blind, double-dummy, parallel group study.

Efficacy and safety assessment of two schemes of oral administration of once-daily extended release metformin (metformin XR) in type 2 diabetic patients previously treated with metformin in combination with sulfonylurea. A 3-month, international, multicentre, randomised, double-blind, double-dummy, parallel group study.

← Back

Study Phase	Phase 2

Therapeutic Area	Metabolism

Indication	Diabetes - Type II

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	GLICLAZIDE, METFORMINE, S005720

Active Substance Code	S005720

Protocol Code	CL2-05720-005

EudraCT Code	2011-006054-82

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.